Arrhythmia Disorder

Among people who had ever smoked, those who quit had reduced risk for incident atrial fibrillation compared with those who had not, according to new data from the UK Biobank.

Arrhythmia disorders in patients with adult congenital heart disease may significantly contribute to hospitalization and mortality risk, according to data published in the Journal of the American Heart Association.

AstraZeneca announced that two post-approval randomized heart- and kidney-related outcome studies of its anti-hyperkalemia drug have been stopped due to slow enrollment and low event rates.

Patients hospitalized for a noncardiac reason with a first-time atrial fibrillation event in-hospital were more likely to have a recurrent event in the 12 months after discharge vs. matched controls with no prior AF, researchers reported.

In this Healio video exclusive, the producer of the Heart Rhythm Society’s HRX meeting on digital health advancements discusses the purpose of and highlights from the meeting.

Data suggest that left atrial scarring observed with 2D long-axis MRI is associated with adverse atrial remodeling and incident clinically detected atrial fibrillation, researchers reported.

iRhythm Technologies announced the U.S. launch of its next-generation cardiac monitoring patch and an enhanced long-term continuous monitoring service.

Atrial fibrillation affects 2.7 million to 6.1 million people in the U.S., according to the American Heart Association, and that burden is expected to rise substantially in the coming years.

Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular heartbeats.

Medtronic announced it received FDA approval for two of its next-generation miniaturized, leadless pacemakers that are less than one-tenth the size of traditional pacemakers.